United States — Centers for Disease Control and Prevention & Moderna
16 shared events · Importance 6 · Last updated Aug 24, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Accidents
United States — Centers for Disease Control and Prevention: The United States — Centers for Disease Control and Prevention is assisting in the safe withdrawal of affected Americans, deploying experts to Africa, and monitoring the outbreak while emphasizing the low risk to the United States.
Moderna: Moderna is a key partner in the urgent high-level coordination meeting convened by United States — Centers for Disease Control and Prevention, potentially involved in assessing medical countermeasures for the Ebola outbreak.
May 15, 2026 · 446 articles
Accidents
United States — Centers for Disease Control and Prevention: The United States — Centers for Disease Control and Prevention>>> declared the Ebola outbreak a Public Health Emergency of Continental Security, emphasizing the urgency of coordinated action and mobilizing resources for response and preparedness.
Moderna: Moderna is one of the entities developing an experimental vaccine for the Bundibugyo virus, which could lead to future revenue and enhance its reputation in vaccine development.
May 18, 2026 · 505 articles
Regulatory
United States — Centers for Disease Control and Prevention: The United States — Centers for Disease Control and Prevention (CDC) advisory committee's formal recommendation is the next step after United States — Food and Drug Administration approval for the vaccine to be widely adopted and potentially made available for free with insurance. However, its current operations are in limbo due to a federal judge's ruling.
Moderna: Moderna is the developer of the mFlusiva mRNA flu vaccine, which is currently under review for approval by the United States — Food and Drug Administration. The positive recommendation from the advisory panel is a significant step towards market entry, potentially boosting its stock and market position in the vaccine sector.
Jun 18, 2026 · 28 articles
Regulatory
United States — Centers for Disease Control and Prevention: CDC's advisory committee may recommend mFLUSIVA, which would influence coverage and uptake; its recommendation is pending.
Moderna: Moderna received its fourth FDA-approved product and first mRNA flu vaccine, boosting its commercial prospects and validating its mRNA platform.
Aug 05, 2026 · 105 articles
International
United States — Centers for Disease Control and Prevention: The United States — Centers for Disease Control and Prevention believes the Ebola outbreak is larger than currently detected and emphasizes the need for community trust in the response.
Moderna: Moderna is utilizing its mRNA technology to develop a vaccine for the Bundibugyo strain of Ebola, with funding from CEPI, aiming to rapidly train the body to fight the virus.
May 21, 2026 · 627 articles
Accidents
United States — Centers for Disease Control and Prevention: Launched a response plan with WHO to improve coordination and surveillance across Africa.
Moderna: Authorized to begin Phase 1 trials for a Bundibugyo vaccine, using mRNA technology. Potential for significant revenue if successful.
Aug 01, 2026 · 301 articles
Tech
United States — Centers for Disease Control and Prevention: United States — Centers for Disease Control and Prevention>>> declared the current outbreak a Public Health Emergency of Continental Security, highlighting the regional impact and need for intervention.
Moderna: Moderna received up to $50 million from CEPI to support the preclinical and early clinical development of its mRNA-based Ebola Bundibugyo vaccine candidate, leveraging its mRNA platform for rapid response.
May 22, 2026 · 36 articles
Domestic
United States — Centers for Disease Control and Prevention: Its officials were involved in the texts; the agency's vaccine recommendations are questioned, but it later recommended vaccination for pregnant women.
Moderna: One of the vaccine manufacturers; similar to Pfizer, minimal direct impact.
Aug 06, 2026 · 17 articles
Accidents
United States — Centers for Disease Control and Prevention: United States — Centers for Disease Control and Prevention is providing data showing transmission has not peaked, informing response strategies. Its monitoring is essential for tracking the outbreak.
Moderna: Moderna is developing an mRNA-based vaccine targeting the Bundibugyo strain, currently in clinical trials. Its progress could offer a more specific solution and enhance its vaccine portfolio.
Aug 22, 2026 · 8 articles
Accidents
United States — Centers for Disease Control and Prevention: US agency providing clinical guidance on Ebola. Its expertise is relevant.
Moderna: Developed an mRNA-based Bundibugyo vaccine candidate, with Phase 1 trials starting in Canada. Its mRNA platform could offer a rapid response to emerging outbreaks.
Mar 09, 2018 · 543 articles
Domestic
United States — Centers for Disease Control and Prevention: CDC is a separate agency; its leadership changes are part of the broader health turmoil but not directly impacted.
Moderna: Moderna, a vaccine maker, had disagreements with the FDA. Overton's vaccine stance may affect future approvals.
Aug 19, 2026 · 101 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how United States — Centers for Disease Control and Prevention and Moderna interact across events, view sentiment trends, and discover connected entities.
Open Dashboard